Project Details
| Short title | Defining the need and clinical efficacy of second-line therapy in primary biliary cholangitis (PBC): a contemporary real-world experience of clinical practice |
|---|---|
| Status | Finished |
| Effective start/end date | 1/09/19 → 11/01/25 |
Funding
- INTERCEPT PHARMACEUTICALS INC